Atul Pande, Director at Karuna Therapeutics, Inc. (KRTX), sold 2,500 shares at $130.44 ($326K) on 2022-01-03, disclosed to the SEC on 2022-01-03.
Open-market sale of $326k KRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2026-06-26 | $57K | — | Filing → |
| IMVT | SELL | 2026-06-16 | $51K | — | Filing → |
| IMVT | SELL | 2026-05-20 | $192K | — | Filing → |